What medications help with anxiety and depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Anxiety and Depression

For patients with both anxiety and depression, SSRIs are the first-line treatment option, with sertraline being the most recommended due to its well-established safety profile and efficacy for both conditions. 1

First-Line Medications

SSRIs (Selective Serotonin Reuptake Inhibitors)

  • Sertraline:

    • Starting dose: 25-50 mg daily
    • Target dose: 50-200 mg daily
    • Most extensively studied SSRI in cardiovascular disease with lower risk of QTc prolongation 2, 1
    • Demonstrated better efficacy for managing melancholia and psychomotor agitation 2
  • Escitalopram:

    • Dose: 10-20 mg daily
    • Well-tolerated alternative to sertraline 1
  • Fluoxetine:

    • Dose: 20 mg daily (may start at 5-10 mg in sensitive patients)
    • Long half-life allowing once-daily dosing 1, 3
    • Caution: May require lower starting doses (5 mg) in patients with panic disorder who may be sensitive to higher doses 3

Common SSRI Side Effects

  • Gastrointestinal: nausea, diarrhea
  • Neurological: headache, insomnia
  • Sexual dysfunction
  • Risk of serotonin syndrome when combined with other serotonergic agents 4
  • Increased risk of suicidal thinking in patients under 24 years 4

Second-Line Medications

SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)

  • Venlafaxine:

    • Starting dose: 37.5 mg daily
    • Target dose: up to 225 mg daily
    • May be superior to fluoxetine for treating anxiety 2, 1
    • Caution: May cause hypertension at high doses 2
  • Duloxetine:

    • Starting dose: 30 mg daily
    • Target dose: 60 mg daily
    • Effective for both anxiety and depression 1
    • Additional benefit for pain symptoms 2

Other Options

  • Mirtazapine:

    • Atypical antidepressant with additional benefits:
    • Helps with sleep disturbances
    • Stimulates appetite (beneficial in patients with weight loss)
    • Safe in cardiovascular disease 2
    • Faster onset of action than SSRIs 2
  • Buspirone:

    • Starting dose: 15 mg daily
    • Target dose: 20-30 mg daily
    • Non-SSRI, non-controlled medication for anxiety
    • Advantages: less sexual dysfunction, lower risk of withdrawal symptoms 1

Medications to Avoid or Use with Caution

  • Benzodiazepines (e.g., alprazolam):

    • While effective for anxiety 5, they should be used cautiously due to:
    • Risk of dependence
    • Sedation and fall risk
    • Not effective for depression
    • Not recommended for long-term use
  • Tricyclic Antidepressants:

    • Significant cardiovascular side effects including hypertension, hypotension, and arrhythmias 2
    • Should be avoided, especially in patients with cardiovascular disease
  • Monoamine Oxidase Inhibitors:

    • Significant cardiovascular side effects 2
    • Multiple drug and food interactions
    • Should be avoided in most patients

Treatment Approach

  1. Start with an SSRI (preferably sertraline) at a low dose and gradually increase

    • Allow 8-12 weeks to evaluate full response 1
    • Monitor for side effects and adjust dose as needed
  2. If partial response or intolerable side effects:

    • Switch to another SSRI or consider an SNRI
    • Approximately 38% of patients do not achieve treatment response during 6-12 weeks of treatment with a single antidepressant 2
  3. For treatment-resistant cases:

    • Consider combination therapy or augmentation strategies
    • Consider referral to a psychiatrist
  4. Non-pharmacological approaches:

    • Cognitive Behavioral Therapy (CBT) is highly effective and should be considered alongside medication 1
    • Regular exercise and stress management techniques can help reduce symptoms

Special Considerations

  • Suicidality monitoring: Patients, especially those under 24 years, should be monitored for emergence of suicidal thoughts, particularly during the first few weeks of treatment 4

  • Discontinuation: Medication should be continued for at least 12-24 months after achieving remission and should be tapered gradually to avoid withdrawal symptoms 1

  • Elderly patients: Start with lower doses and monitor closely for side effects 1

  • Comorbid conditions: Adjust medication choice based on comorbidities (e.g., pain, insomnia, cardiovascular disease)

By following this evidence-based approach, most patients with anxiety and depression can achieve significant symptom improvement and better quality of life.

References

Guideline

Treatment of Anxiety Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Use of low-dose fluoxetine in major depression and panic disorder.

The Journal of clinical psychiatry, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.